The Future of Treating Joint Pain in Horses: The Potential of CBD

Equine Athlete with Joint Pain — Osteoarthritis is one of the leading causes of performance loss in equine athletes. | iStock

Joint pain and osteoarthritis (OA) are significant concerns in the equine community, affecting nearly 60% of equine athletes. These conditions not only contribute to chronic discomfort and inflammation but also impact the overall performance and quality of life for horses. Understanding OA and its treatments is crucial for horse owners, trainers, and veterinarians alike.

Understanding Osteoarthritis in Equine Athletes

Osteoarthritis is characterized by the degeneration of cartilage and the underlying bone, leading to chronic pain, swelling, and decreased range of motion. In the demanding world of equine sports, even minor performance setbacks can lead to substantial consequences. Unfortunately, many current treatments focus solely on managing symptoms rather than halting disease progression.

Current Treatments for OA

The primary management options to alleviate the effects of OA typically include:

Non-steroidal anti-inflammatory drugs (NSAIDs): Widely prescribed, these medications help in reducing pain and inflammation.
Oral joint supplements: These aim to repair or protect cartilage but often yield limited success.
Joint injections: Corticosteroids and newer orthobiologics are common methods but can lead to adverse side effects with prolonged use.

While these treatments can prolong functionality, they often come with risks, especially when employed over lengthy periods. Therefore, the search for alternative therapies that possess anti-inflammatory properties while minimizing side effects is ongoing.

CBD: A Potential Game-Changer?

Cannabidiol (CBD), a compound derived from Cannabis sativa, has emerged as a promising treatment option for a variety of conditions, including OA. CBD is non-psychoactive, meaning it does not induce a “high,” making it a suitable alternative for equine treatment.

Research indicates that CBD interacts with the endocannabinoid system, which plays a vital role in multiple physiological processes, including:

Pain perception
Inflammation modulation
Mood regulation
Immune function

Specifically, in the context of OA, CBD has shown potential in:

Reducing production of pro-inflammatory substances
Alleviating pain sensitivity
Regulating hyperactive immune responses

While anecdotal evidence has surfaced regarding CBD’s benefits, scientific rigor is still required to solidify its efficacy and safety, particularly in equine applications.

Researching the Anti-Inflammatory Effects of CBD

The Page Laboratory is embarking on a three-phase project geared toward investigating the anti-inflammatory potential of CBD in joints. This research is pivotal in refining our understanding of OA and evaluating the effectiveness of CBD as a treatment option.

Phase One: Inducing Inflammation

The first phase involves developing a repeatable and reversible strategy to simulate inflammation in equine joints. This will be achieved by carefully dose-calibrating a pro-inflammatory compound injected into equine knees to induce temporary inflammation. Having an accurate dosage protocol is essential for experimental consistency.

Phase Two: Formulating CBD for Horses

CBD has a low bioavailability when administered to horses, with only about 10% being effectively absorbed. The objective of phase two is to devise an optimal CBD formulation for oral use. Prior research suggests that the solvent used plays a significant role in enhancing CBD absorption; therefore, formulations using fatty substances like sesame or canola oil will be explored. A balance between maximizing therapeutic impact and ensuring palatability will be a key focus.

Phase Three: Evaluating Effectiveness

In the final phase, the findings from the first two phases will be integratively assessed. Horses will be divided between a control group receiving no CBD and a treatment group that does. Key parameters, such as biomarkers associated with inflammation and assessments of lameness through a detailed objective evaluation system, will be measured. This comprehensive approach aims to meticulously analyze any differences in joint response.

Implications for Equines and Beyond

Initial research has shown that CBD could revolutionize the treatment landscape for chronic joint pain in both horses and potentially humans. Given that approximately 45% of people are likely to develop OA at some point in their lives, the results of this equine study may extend beyond veterinary medicine into broader healthcare applications.

The culmination of this research is aimed at not only refining a model for joint inflammation but also assessing CBD’s role in the management of joint pain in horses. Such advances could redefine treatment standards and improve the quality of life for affected animals.

Editor’s note: This article is based on research funded by underwriters at Lloyd’s, London, and other associates. It features insights from Jenna McPeek, a PhD Graduate Student at the University of Kentucky’s Gluck Equine Research Center, and Allen Page, DVM, PhD, Assistant Professor at the same institution.

What are common symptoms of osteoarthritis in horses?

Common symptoms include joint swelling, pain, decreased range of motion, and noticeable lameness, especially following exercise.

How does CBD help with joint pain?

CBD has anti-inflammatory properties that potentially reduce pain sensitivity and modulate immune responses, leading to decreased inflammation in joints.

Are there any side effects of using CBD in horses?

While CBD is generally considered safe, potential side effects may include drowsiness, gastrointestinal discomfort, or changes in appetite. Ongoing research aims to clarify its overall safety profile.

What is the role of the endocannabinoid system in pain management?

The endocannabinoid system regulates various physiological processes, including pain perception and inflammation, helping to maintain homeostasis in the body.